tiprankstipranks
Trending News
More News >
Advertisement

DWAS - AI Analysis

Compare

Top Page

DWAS

Invesco DWA SmallCap Momentum ETF (DWAS)

Rating:62Neutral
Price Target:
$102.00
The Invesco DWA SmallCap Momentum ETF (DWAS) has a balanced rating, reflecting both strengths and challenges among its holdings. Bel Fuse Inc. stands out as a key contributor to the fund’s rating due to its robust financial performance, operational efficiency, and bullish technical momentum. However, weaker holdings like thredUP and Amylyx Pharmaceuticals, which face significant financial and profitability challenges, may have held back the overall rating. A notable risk factor is the ETF's exposure to small-cap stocks, which can be more volatile and sensitive to market conditions.
Positive Factors
Strong Top Holdings
Several top holdings, such as Centrus Energy and BitMine Immersion Technologies, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Momentum Strategy
The ETF focuses on small-cap stocks with strong momentum, which can lead to higher growth potential in favorable market conditions.
Sector Diversification
The fund is spread across multiple sectors, including Health Care, Technology, and Industrials, reducing reliance on any single industry.
Negative Factors
High Expense Ratio
The ETF’s expense ratio of 0.6% is higher than many passive funds, which could eat into long-term returns.
Overwhelming U.S. Exposure
With nearly 100% of its assets in U.S. companies, the ETF lacks geographic diversification and is vulnerable to domestic market downturns.
Volatility Risk
Small-cap stocks are inherently more volatile, which could lead to larger swings in the ETF’s performance during market turbulence.

DWAS vs. SPDR S&P 500 ETF (SPY)

DWAS Summary

The Invesco DWA SmallCap Momentum ETF (DWAS) is an investment fund that focuses on small companies in the U.S. with strong momentum, meaning their stock prices have been rising quickly. It follows the Dorsey Wright SmallCap Technical Leaders Index, which picks companies showing solid growth trends. Some of its top holdings include Amprius Technologies and Centrus Energy. Investors might consider DWAS if they’re looking for growth opportunities and want to diversify into smaller, fast-moving companies. However, it’s important to know that small-cap stocks can be more volatile, meaning their prices can go up and down more dramatically than larger companies.
How much will it cost me?The Invesco DWA SmallCap Momentum ETF (DWAS) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on small-cap stocks with strong momentum, which requires more research and management compared to passively managed ETFs. It’s designed for investors seeking growth opportunities in dynamic, smaller companies.
What would affect this ETF?The DWAS ETF, focused on U.S. small-cap stocks with strong momentum, could benefit from economic growth and innovation in sectors like Health Care and Technology, which make up a significant portion of its holdings. However, it may face challenges during periods of economic uncertainty or rising interest rates, which can negatively impact small-cap companies and momentum-driven strategies. Regulatory changes or sector-specific headwinds could also influence the performance of its top holdings.

DWAS Top 10 Holdings

The Invesco DWA SmallCap Momentum ETF (DWAS) is riding the wave of small-cap growth, with standout performers like Centrus Energy and Ondas Holdings driving gains thanks to their strong technical momentum and strategic advancements. However, laggards such as thredUP and Porch Group are holding the fund back, weighed down by operational inefficiencies and financial risks. With a notable tilt toward health care and technology sectors, DWAS is heavily concentrated in U.S.-based companies, making it a dynamic but domestically focused play for investors seeking momentum-driven opportunities.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Cidara Therapeutics1.46%$10.62M$2.67B685.21%
55
Neutral
Amprius Technologies Inc1.41%$10.22M$1.49B693.33%
60
Neutral
thredUP1.37%$9.99M$1.14B1296.68%
51
Neutral
Bel Fuse Inc1.34%$9.74M$1.93B99.90%
77
Outperform
Centrus Energy1.33%$9.64M$6.62B246.54%
64
Neutral
BitMine Immersion Technologies1.28%$9.32M$14.96B1339.45%
Tutor Perini1.26%$9.12M$3.61B157.34%
64
Neutral
Opendoor Technologies1.22%$8.86M$5.87B345.25%
51
Neutral
Climb Global Solutions1.17%$8.47M$616.63M25.62%
75
Outperform
Ondas Holdings1.16%$8.46M$2.37B725.03%
45
Neutral

DWAS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
91.85
Positive
100DMA
88.25
Positive
200DMA
85.37
Positive
Market Momentum
MACD
0.78
Positive
RSI
51.51
Neutral
STOCH
56.05
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DWAS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 94.34, equal to the 50-day MA of 91.85, and equal to the 200-day MA of 85.37, indicating a neutral trend. The MACD of 0.78 indicates Positive momentum. The RSI at 51.51 is Neutral, neither overbought nor oversold. The STOCH value of 56.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DWAS.

DWAS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$731.60M0.60%
62
Neutral
$946.44M0.48%
72
Outperform
$914.56M0.60%
65
Neutral
$705.87M0.20%
65
Neutral
$634.74M0.40%
68
Neutral
$633.86M0.38%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DWAS
Invesco DWA SmallCap Momentum ETF
93.97
0.66
0.71%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
FYX
First Trust Small Cap Core AlphaDEX Fund
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
SMDV
ProShares Russell 2000 Dividend Growers ETF
EES
WisdomTree U.S. SmallCap Fund
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement